Overview
Jeff Tornheim, M.D., MPH, is a member of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, and is a term member of the Council on Foreign Relations. Dr. Tornheim graduated with a B.A. in International Development and Economics from Brandeis University, received his medical and public health degree from the Mount Sinai School of Medicine, completed a combined residency in Internal Medicine and Pediatrics at Yale University School of Medicine and a clinical fellowship in Infectious Diseases at Johns Hopkins University School of Medicine. Prior to completing his medical education, he worked on strengthening health systems for returning refugees to South Sudan, studied the epidemiology of pneumonia and diarrhea in Kenya with the Centers for Disease Control and Prevention (CDC) International Emerging Infections Program, studied adherence to latent tuberculosis treatment at the New York City Department of Health and Mental Hygiene in the Bureau of TB Control, and volunteered in an East Harlem free clinic. During his public health degree, he evaluated the impact of water policy on rates of pediatric diarrhea as well as Chagas Disease epidemiology and treatment in Bolivia through the Fogarty International Clinical Scholars Program. His interest in clinical outcomes for underserved populations has led to research, teaching, and clinical practice in Bolivia, India, Kenya, Peru, Rwanda, South Africa, South Sudan, Uganda, and the United States. His current NIH-supported research explores the application of whole genome sequencing, drug level testing, transcriptional and metabolomic profiling, and biomarker assessments to improved health outcomes in the treatment of adults and children with drug resistant tuberculosis in India.
His clinical expertise encompasses Long Haul COVID, Bacterial Meningitis, Meningitis, and HIV/AIDS.
Dr. Tornheim is board certified in American Board Of Internal Medicine and American Board Of Pediatrics. He is actively involved in clinical research, co-authoring 50 peer reviewed articles. Dr. Tornheim is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
Locations
Baltimore, MD 21287
4940 Eastern Avenue, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine. Dr. Durbin is currently accepting new patients.
The Johns Hopkins Hospital
Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B. Dr. Sulkowski is board certified in American Board Of Internal Medicine. Dr. Sulkowski is currently accepting new patients.
Office
Kathleen Neuzil is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Neuzil is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.
Frequently Asked Questions about Dr. Jeffrey A. Tornheim
How do I make an appointment with Dr. Jeffrey A. Tornheim?
You can book an appointment with Dr. Jeffrey A. Tornheim by calling their office at 410-955-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jeffrey A. Tornheim a top-rated expert for Long Haul COVID?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey A. Tornheim is classified as an Experienced expert for Long Haul COVID, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jeffrey A. Tornheim specialize in?
While Dr. Jeffrey A. Tornheim is a Infectious Disease, they have specific expertise in Long Haul COVID, Bacterial Meningitis, and Meningitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Jeffrey A. Tornheim participate in research or clinical trials?
Yes. Dr. Jeffrey A. Tornheim has published 50 articles and abstracts on conditions like Long Haul COVID. You can view a list of Dr. Jeffrey A. Tornheim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jeffrey A. Tornheim accept my insurance?
Dr. Jeffrey A. Tornheim accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bacterial MeningitisDr. Tornheim isExperienced. Learn about Bacterial Meningitis.
- Chagas DiseaseDr. Tornheim isExperienced. Learn about Chagas Disease.
- COVID-19Dr. Tornheim isExperienced. Learn about COVID-19.
- HIV/AIDSDr. Tornheim isExperienced. Learn about HIV/AIDS.
- Long Haul COVIDDr. Tornheim isExperienced. Learn about Long Haul COVID.
- MeningitisDr. Tornheim isExperienced. Learn about Meningitis.
- Severe Acute Respiratory Syndrome (SARS)Dr. Tornheim isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Tuberculous MeningitisDr. Tornheim isExperienced. Learn about Tuberculous Meningitis.